Projects funded by the NCN
Involvement of RIPk4 in melanoma malignacy regulated by Wnt/b-catenin signaling.
2018/31/B/NZ5/01423
Keywords:
RIPK4 b-catenin melanoma malignacy apoptosis
Descriptors:
- NZ1_2: Biochemistry
- NZ3_7: Signal transduction
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
dr hab. Agnieszka Wolnicka-Głubisz
Number of co-investigators in the project: 10
Call: OPUS 16 - announced on 2018-09-14
Amount awarded: 1 456 500 PLN
Project start date (Y-m-d): 2019-07-05
Project end date (Y-m-d): 2024-07-04
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.